Drugs in secondary stroke prevention
نویسندگان
چکیده
منابع مشابه
Secondary prevention of stroke.
Stroke has been defined as a rapid onset of focal neurological deficit lasting more than 24 hours, with no apparent cause other than disruption of the blood supply to the brain (World Health Organization, 1989). A transient ischaemic attack (TIA) refers to a similar presentation that resolves within 24 hours (Hankey and Warlow, 1994). Approximately 15% of strokes are haemorrhagic, with the rest...
متن کاملAntiplatelets in Secondary Stroke Prevention
The aim of this review is to provide evidence-based recommendations on the secondary prevention of atherothrombotic ischemic stroke. Antiplatelets are the major therapy for the secondary stroke prevention. The most commonly used antiplatelets agents are aspirin, clopidogrel, and extended-release dipyridamole. A lot of progress had been made in last years regarding aspirin resistance and genotyp...
متن کاملUpdate of secondary stroke prevention.
Secondary prevention aims at preventing a stroke after a transient ischaemic attack (TIA) or a recurrent stroke after a first stroke. About 80–85% of patients survive a first ischaemic stroke [1,2]. Of those, between 8 and 15% suffer a recurrent stroke in the first year. The risk of stroke recurrence is highest in the first few weeks and declines over time [3–5]. The risk of recurrence depends ...
متن کاملSecondary prevention of recurrent stroke.
Risk of Recurrent Stroke The risk of stroke after a transient ischemic attack (TIA) or mild ischemic stroke was 10% within 1 week and 18% within the first 3 months in Oxfordshire, UK, in 2002 to 2003.1 This substantial early risk is 3-fold higher if the TIA or ischemic stroke is caused by large artery disease and 5-fold lower if the cause is small artery disease.2 The prevalence and level of ot...
متن کاملAntivitamin K drugs in stroke prevention.
Among the different subtypes of ischaemic strokes, almost 20 % are of cardiac origin. Different are the causes of cardioembolic stroke, but the most common is the atrial fibrillation, a supraventricular arrhythmia. Appropriate use of antiplatelet drugs and anticoagulants after transient ischaemic attack (TIA) or ischaemic stroke depends on whether the underlying cause is cardioembolic or of pre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Australian Prescriber
سال: 2021
ISSN: 1839-3942
DOI: 10.18773/austprescr.2021.018